The U.S. women's health market is on track to reach $99.7 billion by 2032, expanding at a compound annual growth rate of 4.67%, according to new data from Mordor Intelligence. The growth trajectory is being driven by rising clinical awareness of women-specific conditions, increased demand for preventive screenings, and broader adoption of advanced diagnostics — dynamics that carry direct implications for the functional foods, nutraceutical, and supplement categories.
What's Fueling Growth
Menopause care, fertility services, and digital health tools are identified as the primary growth engines within the broader market. For the functional nutrition industry, these segments align closely with a surge in condition-specific product development — from phytoestrogen-based botanicals and magnesium formulations targeting perimenopausal symptom relief, to myo-inositol and folate-forward supplements positioned for fertility support. Adaptogenic ingredients such as ashwagandha and shatavari have also gained shelf presence as mainstream brands compete for the hormonally-aware consumer.
Preventive health is an equally important driver. As more women engage proactively with screenings and wellness protocols earlier in life, the addressable window for functional nutrition expands beyond the traditional 45-plus menopause cohort. Brands that can anchor structure-function claims to clinically relevant endpoints — bone density, mood, metabolic health, cardiovascular markers — stand to capture outsized share in a market that is maturing rapidly.
Operator Implications
For ingredient suppliers and finished-product formulators, the data signals sustained demand for women's-health-specific positioning well into the next decade. The menopause nutrition subcategory in particular has moved from niche to mainstream, with major retailers now dedicating dedicated shelf sets to the segment. Standardized botanical extracts with documented bioavailability data — and, where available, double-blind, placebo-controlled clinical trial support — are increasingly the price of entry for premium positioning.
Digital health adoption noted in the Mordor Intelligence forecast also points to a convergence opportunity: supplement brands that can integrate with femtech platforms, wearable data, or telehealth channels gain a distribution and engagement edge that purely brick-and-mortar plays cannot replicate. Subscription and direct-to-consumer models remain the dominant route for personalized women's wellness stacks, though mass and specialty retail are closing the gap as category legitimacy grows.
For operators tracking adjacent demand signals, the GLP-1 and weight-management wave intersects meaningfully here as well — women represent the majority of GLP-1 therapy patients, creating a parallel need for micronutrient repletion, protein optimization, and gut-health support formulations designed around their physiology. Brands that can articulate a credible science story across these intersecting needs are well-positioned as the $99.7 billion market continues to segment and specialize through 2032. Coverage of the menopause nutrition and women's wellness segments at Functional News tracks how ingredient suppliers and brands are responding to this structural demand shift.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
